{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:54:31Z","timestamp":1780473271368,"version":"3.54.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Previously, dihydroceramide (d18:0\/24:0) (dhCer (d18:0\/24:0)) was reported to be a potential biomarker for acute-on-chronic liver failure (ACLF) prognosis. In this study, we further explored the role of dhCer (d18:0\/24:0) in the progression of ACLF to validate the biomarker using ACLF rat model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>ACLF rats were sacrificed at 4 and 8 h post-D-galactosamine (D-gal)\/lipopolysaccharide (LPS) administration to investigate the liver biochemical markers, prothrombin time and liver histopathology. Change in dhCer and other sphingolipids levels were investigated by high-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS\/MS). Rats were treated with N-(4-hydroxyphenyl) retinamide (4-HPR) to examine the mortality rate and its role in improving ACLF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>LPS\/D-gal administration resulted in significant elevation in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. Prothrombin time was prolonged and histopathological examination showed abnormality. HPLC-MS\/MS results showed total dhCer levels in ACLF group (64.10\u200a\u00b1\u200a8.90\u200apmol\/100\u200a\u03bcL, 64.22\u200a\u00b1\u200a6.78\u200apmol\/100\u200a\u03bcL for 4 and 8 h, respectively) were decreased significantly compared with control group (121.61\u200a\u00b1\u200a23.09\u200apmol\/100\u200a\u03bcL) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.05). In particular, dhCer (d18:0\/24:0), dhCer (d18:0\/20:0), and dhCer (d18:0\/22:0) levels were decreased. Treatment with 4-HPR significantly increased the levels of dhCers, including dhCer (d18:0\/24:0) compared with ACLF group, for the level of dhCer (d18:0\/24:0) in 4-HPR group was 20.10\u200a\u00b1\u200a8.60\u200apmol\/100\u200a\u03bcL and the level of dhCer (d18:0\/24:0) in ACLF group was 9.74\u200a\u00b1\u200a2.99\u200apmol\/100\u200a\u03bcL (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.05). This was associated with reduced mortality rate and prolonged survival time. The ALT and AST in 4-HPR group were significantly decreased compared with ACLF group. The prothrombin time of 4-HPR group (41.49\u200as) was significantly lower than the prothrombin time of ACLF group (57.96\u200as) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.05). 4-HPR also decreased plasma ammonia levels slightly, as the plasma ammonia levels in 4-HPR group and ACLF group were 207.37\u200a\u00b1\u200a60.43, 209.15\u200a\u00b1\u200a60.43\u200a\u03bcmol\/L, respectively. Further, 4-HPR treatment improved histopathological parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>DhCer, especially dhCer (d18:0\/24:0), is involved in the progression of ACLF. Increasing the levels of dhCer can reduce the mortality rate of ACLF rats and alleviate liver injury.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000000601","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T13:02:56Z","timestamp":1577451776000},"page":"198-204","source":"Crossref","is-referenced-by-count":9,"title":["Role of dihydroceramides in the progression of acute-on-chronic liver failure in rats"],"prefix":"10.1097","volume":"133","author":[{"given":"Fang-Fang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"R1-20230813","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"key":"R2-20230813","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jceh.2017.05.002","article-title":"Toward a better definition of acute-on-chronic liver failure","volume":"7","author":"Duseja","year":"2017","journal-title":"J Clin Exp Hepatol"},{"key":"R3-20230813","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"R4-20230813","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.trsl.2018.05.006","article-title":"The assessment of multipotent cell transplantation in acute-on-chronic liver failure: a systematic review and meta-analysis","volume":"200","author":"Xue","year":"2018","journal-title":"Transl Res"},{"key":"R5-20230813","first-page":"170","article-title":"Liver transplantation in China: problems and their solutions","volume":"3","author":"Wu","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R6-20230813","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1194\/jlr.R031278","article-title":"Sphingolipids: regulators of crosstalk between apoptosis and autophagy","volume":"54","author":"Young","year":"2013","journal-title":"J Lipid Res"},{"key":"R7-20230813","first-page":"2881","article-title":"Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide","volume":"30","author":"Ahn","year":"2010","journal-title":"Anticancer Res"},{"key":"R8-20230813","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbalip.2014.09.021","article-title":"Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity","volume":"1851","author":"Rodriguez-Cuenca","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"R9-20230813","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.bbrc.2017.10.110","article-title":"Dihydroceramide is a key metabolite that regulates autophagy and promotes fibrosis in hepatic steatosis model","volume":"494","author":"Lee","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"R10-20230813","doi-asserted-by":"crossref","first-page":"e104988","DOI":"10.1371\/journal.pone.0104988","article-title":"Serum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failure","volume":"9","author":"Qu","year":"2014","journal-title":"PLoS One"},{"key":"R11-20230813","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.apsb.2016.09.003","article-title":"Establishment of a new acute-on-chronic liver failure model","volume":"7","author":"Li","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"R12-20230813","doi-asserted-by":"crossref","first-page":"e52454","DOI":"10.1371\/journal.pone.0052454","article-title":"Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide","volume":"7","author":"Qu","year":"2012","journal-title":"PLoS One"},{"key":"R13-20230813","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10495-006-5882-8","article-title":"Dihydroceramide hinders ceramide channel formation: Implications on apoptosis","volume":"11","author":"Stiban","year":"2006","journal-title":"Apoptosis"},{"key":"R14-20230813","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2011.11.001","article-title":"Chain length-specific properties of ceramides","volume":"51","author":"Gr\u00f6sch","year":"2012","journal-title":"Prog Lipid Res"},{"key":"R15-20230813","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2337\/db14-0359","article-title":"Increased dihydroceramide\/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function","volume":"64","author":"Barbarroja","year":"2015","journal-title":"Diabetes"},{"key":"R16-20230813","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cmet.2012.04.002","article-title":"A ceramide-centric view of insulin resistance","volume":"15","author":"Chavez","year":"2012","journal-title":"Cell Metab"},{"key":"R17-20230813","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.bbamem.2015.07.013","article-title":"Ceramide channels: destabilization by Bcl-xL and role in apoptosis","volume":"1848","author":"Chang","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"R18-20230813","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.gastro.2017.10.050","article-title":"Nanoliposome C6-ceramide increases the anti-tumor immune response and slows growth of liver tumors in mice","volume":"154","author":"Li","year":"2018","journal-title":"Gastroenterology"},{"key":"R19-20230813","doi-asserted-by":"crossref","first-page":"e3773","DOI":"10.1097\/MD.0000000000003773","article-title":"Up-regulation of plasma hexosylceramide (d18: 1\/18: 1) contributes to genotype 2 virus replication in chronic hepatitis C: a 20-year cohort study","volume":"95","author":"Zhang","year":"2016","journal-title":"Medicine"},{"key":"R20-20230813","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3892\/mmr.2015.3361","article-title":"Plasma sphingolipids: potential biomarkers for severe hepatic fibrosis in chronic hepatitis C","volume":"12","author":"Li","year":"2015","journal-title":"Mol Med Rep"},{"key":"R21-20230813","doi-asserted-by":"crossref","first-page":"24754","DOI":"10.1074\/jbc.M111.250779","article-title":"Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide","volume":"286","author":"Rahmaniyan","year":"2011","journal-title":"J Biol Chem"},{"key":"R22-20230813","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1128\/MCB.00226-13","article-title":"Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling","volume":"33","author":"Siddique","year":"2013","journal-title":"Mol Cell Biol"},{"key":"R23-20230813","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s10495-016-1267-9","article-title":"Dihydroceramide-desaturase-1-mediated caspase 9 activation through ceramide plays a pivotal role in palmitic acid-induced HepG2 cell apoptosis","volume":"21","author":"Zhu","year":"2016","journal-title":"Apoptosis"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T08:20:17Z","timestamp":1691914817000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,26]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000000601","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,26]]}}}